COLLABORATION AGREEMENTCollaboration Agreement • November 14th, 2007 • Aradigm Corp • Electromedical & electrotherapeutic apparatus • California
This Collaboration Agreement (the “Agreement”) is entered into and made effective as of August 31, 2007 (the “Effective Date”) by and between Aradigm Corporation, a California corporation having its principal place of business at 3929 Point Eden Way, Hayward, CA 94545 (“Aradigm”), and CyDex, Inc., a Delaware corporation having its principal place of business at 10513 W. 84th Terrace, Lenexa, KS 66214 (“CyDex”). Aradigm and CyDex are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EXCLUSIVE LICENSE, DEVELOPMENT, AND COMMERCIALIZATION AGREEMENTAnd Commercialization Agreement • November 14th, 2007 • Aradigm Corp • Electromedical & electrotherapeutic apparatus • New York
This Exclusive License, Development, and Commercialization Agreement (the “Agreement”) is entered into as of August 30, 2007 (the “Effective Date”) by and between Aradigm Corporation, a California corporation having its principal office at 3929 Point Eden Way, Hayward, California 94545 (“Aradigm”), and Lung Rx, Inc., a wholly-owned subsidiary of United Therapeutics Corporation, a Delaware corporation, having an address of 1110 Spring Street, Silver Spring, Maryland 20910 (“Lung Rx”). Aradigm and Lung Rx may be referred to individually as a “Party”, and collectively as the “Parties”.
